Cardiac monitoring during intervention is important to quickly manage any arrhythmias and on-going ischemia. Early identification of rhythm changes, ST changes and QT/QTc changes is important to provide appropriate treatment and assure positive outcomes. In addition, TAVR can have associated AV block, and post-procedure monitoring is indicated to detect and manage.
GE’s CARESCAPETM monitoring portfolio analyzes four independent, simultaneous ECG leads that helps earlier and more accurately identify arrhythmias. In addition, the technology continuously monitors up to 12 leads including ST trend views, and QT/QTc measurements.